Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS $0.88-$0.96, revenue $4.46-$4.52 billion.
Original Image Link
Source:markets.businessinsider.com
Original Image Link
Source:markets.businessinsider.com
Posted: 2024-05-08 11:40:00